REMOTE: FitLife Brands seeks Chief Marketing Officer (USA / Canada)

🔥 RESEARCH & INSIGHT 🔥 :

FitLife Brands (NASDAQ: FTLF) is a $120M+ nutritional supplements roll-up that's either a hidden gem or a potential value trap, depending on how you read the tea leaves. Based in Omaha (5214 S. 136th Street), CEO Dayton Judd—a Harvard MBA with McKinsey and hedge fund experience who owns 58.7% of the company (9,384,144 shares outstanding as of April 2025) — has spent the last five years acquiring distressed supplement brands and trying to flip them profitable.

The portfolio now includes 13+ brands: MusclePharm (the fallen icon with 564K Instagram followers), Dr. Tobias (Amazon-native digestive health), Irwin Naturals (30-year-old mass market brand sold at CVS/Walmart), and a collection of smaller sports nutrition names.

Here's what matters: This isn't a marketing-driven company. It's a finance-driven consolidation play. Mr. Judd buys cheap assets, cuts costs, and tries to extract cash. The company generates positive EBITDA (expected $20-25M in 2025) despite declining revenue, which tells you everything about the culture. They're lean—87 employees managing $120M in revenue means roughly $1.4M per employee, which is either impressively efficient or dangerously understaffed.

The CMO role doesn't exist today. You'd be building the function from scratch, which sounds exciting until you realize there's likely no marketing function because the CEO doesn't think he needs one.

🟥 GET UNSTUCK: Book an hour with Harry. (Includes a 3-month membership to NEXTgig™)

---

Market/Industry Context: Why This Matters Now

The supplement industry is simultaneously booming and brutal. Global sports nutrition is projected to hit $138B by 2033, growing at 7.3% CAGR. Sounds great. But here's the reality: Amazon now controls $10B+ in annual supplement sales—double what it was in 2019—and that concentration is killing brands that can't play Amazon's game. The platform takes 30-40% in fees, advertising costs are rising 15-20% annually, and algorithm changes can crater your revenue overnight. Ask Dr. Tobias, which dropped 16% year-over-year primarily due to "session count decline"—Amazon-speak for "we stopped showing your products to people."

The retail pharmacy channel isn't much better. CVS and Walgreens are closing hundreds of stores, optimizing footprints, and pressuring suppliers on price. GNC, historically a major distribution partner, filed bankruptcy in 2020 and shuttered 800-1,200 locations. The supplement industry just lost a significant chunk of its traditional retail infrastructure.

Meanwhile, consumer behavior is shifting faster than legacy brands can adapt. Gen Z and Millennials want clean-label, plant-based, sustainably sourced supplements sold through TikTok Shop and influencer partnerships. They don't shop at GNC or browse Amazon's supplement aisle—they buy what their favorite fitness creator recommends. FitLife's portfolio skews traditional: whey protein, pre-workout powders, digestive enzymes. Nothing inherently wrong with that, but you're competing for yesterday's customer while tomorrow's customer doesn't know you exist.

The tariff situation adds another layer of complexity. FitLife specifically cited 25% tariffs on MRC's skincare brands in Q2 2025, which cut gross margins approximately 50% for those specific products. Beyond that, broader tariffs on botanical ingredients from China and India (ranging 20-145% on certain ingredients) are pressuring COGS across the industry. When your gross margins are already compressing (down to 42.8% from 44.8% year-over-year), ingredient cost inflation is a real problem.

Here's the uncomfortable truth: FitLife is fighting a three-front war. Amazon is squeezing margins and controlling visibility. Retail is contracting. And the company's brand portfolio feels increasingly irrelevant to the fastest-growing customer segments. You'd be walking into a situation where the fundamentals of the business model are under attack, and nobody seems to have a plan beyond "acquire more brands and manage costs."

🟥 GET UNSTUCK: Book an hour with Harry. (Includes a 3-month membership to NEXTgig™)

---

SWOT Analysis: What You're Likely Walking Into

Strengths:

Strong Balance Sheet Gives You Runway

FitLife closed Q2 with $6.6M cash, only $4.3M net debt (0.3x EBITDA pre-Irwin), and generated $13.4M trailing twelve-month EBITDA. Post-Irwin acquisition (closed August 8, 2025 for $42.5M), leverage increased to less than 2.25x EBITDA, but that's still manageable. This matters because you'll have budget to invest. The question is whether Mr. Judd will actually give it to you. His track record suggests he acquired brands by being disciplined about capital, not by spending it on marketing. Good luck convincing a value investor to double marketing spend.

Real Brand Assets with Actual Equity

MusclePharm isn't a nobody. At its peak, the brand did $166M in annual revenue and sponsored elite athletes. The Instagram following (564K) is real engagement, not bought followers. Dr. Tobias became Amazon's #1 selling Omega-3 through product quality and review management, not just paid ads. Irwin Naturals has been on CVS shelves for 30+ years. These aren't private-label knockoffs—there's actual brand recognition and customer loyalty to build on. The challenge is that all three brands have fallen from their peaks and need serious revitalization.

Multi-Channel Distribution Reduces Single-Point Risk

The 65% online / 35% retail split means you're not completely at Amazon's mercy, even though it feels that way. Irwin's 80 SKUs at CVS and strong presence at Walmart give you leverage. You can theoretically drive customers from retail to higher-margin online channels through packaging QR codes and in-store marketing. Whether CVS will let you do that without threatening to delist you is another question entirely.

Proven M&A Integration Playbook

Mr. Judd has successfully integrated four acquisitions (Nutrology, Mimi's Rock, MusclePharm, Irwin) with minimal incremental headcount. Mimi's free cash flow increased from ~$1M to $5M+ annually post-acquisition. MusclePharm was integrated with only one new hire. This suggests the operational infrastructure can scale. For you as CMO, this means future acquisitions could give you bigger brands to market without needing to rebuild systems each time.

✅ subscribe

---

Weaknesses:

No Marketing Function Exists Today

This CMO role is being created, which means marketing has likely been fragmented across 13 brands with no central strategy, no unified customer database, and likely no meaningful marketing team. You'd be building from zero with a CEO who demonstrably didn't think marketing mattered enough to hire someone before now. What changed? Revenue is declining (Q2 2025 down 5% year-over-year to $16.1M), and Mr. Judd likely realized cost-cutting alone won't work. You're being brought in to fix a problem he doesn't fully understand, which is a challenging starting position.

Significant Amazon Dependency

Amazon likely accounts for an estimated 40-50% of total revenue (within the 65% online segment)—meaning Amazon likely represents the single largest revenue source for the entire company. This platform just proved it can tank your largest brand (Dr. Tobias, -16% YoY) by reducing "session counts." Amazon controls your visibility, your pricing power, and your customer data. You can't remarket to customers who bought on Amazon. You can't build direct relationships. Amazon takes 30-40% in fees and advertising costs keep rising. This isn't a partnership—it's a hostage situation. And based on the Amazon Unboxed 2024 announcements, Amazon is doubling down on AI-driven attribution and multi-touch measurement, which means they'll have even more data about your customers than you do.

Technology Stack Likely Under-Invested

With 87 employees managing 13 brands across multiple channels, sophisticated marketing technology seems unlikely. The lean operational model and absence of publicly disclosed KPIs (no conversion rates, CAC, CLV, or retention metrics in earnings reports) suggest either the systems don't exist or the data isn't favorable. You'd likely need to invest $500K-1M in technology infrastructure (unified customer data platform, marketing automation, proper attribution) before you could execute modern marketing tactics. Whether Mr. Judd will approve that investment remains uncertain.

Organizational Chaos Across 13 Brands

There's no brand architecture. MusclePharm, PMD Sports, and iSatori all compete in sports nutrition with no clear differentiation. Customers buying Dr. Tobias don't know it's related to MusclePharm. No cross-brand loyalty program. No unified "FitLife Family" positioning. It's 13 separate businesses pretending to be one company. This isn't a portfolio—it's a collection of assets that happen to share a corporate owner. Fixing this requires executive alignment, brand strategy work, packaging redesigns, and 18-24 months. You ready for that fight?

CEO's Background Suggests Marketing Skepticism

Dayton Judd is a numbers guy: McKinsey consultant, hedge fund manager, value investor. These people respect ROAS, payback periods, and unit economics. They do not naturally respect brand building, content marketing, or "investing in awareness." His track record shows he buys cheap assets and cuts costs—not the profile of someone who'll greenlight a $3M brand refresh or six-figure content marketing budget. You'll likely spend significant time justifying every dollar instead of actually building marketing capability.

🟥 GET UNSTUCK: Book an hour with Harry. (Includes a 3-month membership to NEXTgig™)

---

Opportunities:

Irwin's $60M Revenue is ~95% Offline

This is the massive white space. Irwin Naturals generates ~$60M annually (adjusted for Costco U.S. loss), with approximately 95% coming through CVS, Walmart, and Walgreens wholesale channels. Less than 5% comes from online. If you can migrate even 10% of that revenue to higher-margin DTC/Amazon (45% margins vs. 35% wholesale), that's $6M in revenue with meaningfully better economics. The challenge: retail partners will resist. They didn't give Irwin shelf space so FitLife could poach customers online. Navigate this carefully or risk delisting.

MusclePharm Brand Resurrection is Real

564K Instagram followers is an asset most brands would kill for. MusclePharm peaked at $166M revenue—the brand equity exists, it's just dormant. A proper brand relaunch with influencer partnerships, TikTok content, product reformulations (plant-based options, clean-label), and nostalgia marketing could scale from ~$10M to $30M+ annually. This is your hero project. If you can point to MusclePharm's comeback, you'll have credibility for everything else.

Amazon Unboxed 2024 Tools Level the Playing Field

The new AI Creative Studio, Multi-Touch Attribution, and Audience Bid Boosting tools announced at Amazon Unboxed democratize capabilities that previously required massive teams. You could use AI-generated creative assets to scale faster, implement proper full-funnel attribution to prove marketing's value, and leverage AMC (Amazon Marketing Cloud) audiences to improve targeting precision. If you adopt these tools aggressively while competitors are still figuring them out, you gain 12-18 months of advantage.

Cross-Brand Customer Data is Untapped Gold

Nobody's connecting the dots. A customer who buys MusclePharm protein and Dr. Tobias Omega-3 is a high-value multi-brand shopper, but FitLife likely doesn't know who they are because the data appears to live in silos. Build a unified customer data platform, implement a "FitLife Rewards" loyalty program, and create subscription bundles ("Performance Stack" with MusclePharm + Dr. Tobias + iSatori). Increasing cross-brand purchase rate could add significant revenue without acquiring a single new customer.

Programmatic Advertising Infrastructure Appears Absent

FitLife likely doesn't use Amazon DSP, The Trade Desk, or programmatic retargeting effectively based on the company's lean operations and lack of disclosed sophisticated marketing capabilities. Implementing a proper DSP strategy with custom audiences built from AMC data could reduce CAC by 20-30% while improving targeting precision. This requires expertise the company doesn't have, but it's not capital-intensive—it's execution and know-how.

✅ subscribe

---

Threats:

Dr. Tobias Decline is a Warning

When your second-largest brand drops 16% in a single year due to Amazon algorithm changes, and management's stated plan is "increase ad spend and improve SEO," that's concerning. If Amazon decides to promote its private-label Omega-3 (Solimo brand) over Dr. Tobias, there's nothing you can do. The session count decline shows Amazon controls the traffic spigot. You don't. This threat should concern you because it proves how fragile the business model is when concentrated on a single platform.

Retail Pharmacy Meltdown Accelerates

CVS and Walgreens aren't just "optimizing stores"—they're facing significant challenges. CVS stock is down substantially from highs, closing stores, cutting costs. If CVS decides Irwin's 80 SKUs generate insufficient profit per square foot, they'll cut the assortment by half or demand better pricing. Meanwhile, Mark Cuban's Cost Plus Drug Company and Amazon Pharmacy are creating new competitive dynamics. Irwin's $60M revenue base could face pressure over three years through no fault of your marketing execution.

Tariff Volatility Destroys Unit Economics

FitLife specifically called out 25% tariffs on MRC's skincare brands, which cut gross margins approximately 50% for those products. Broader botanical ingredient tariffs (20-145% on certain ingredients from China/India) create additional COGS pressure. If tariffs expand or ingredient costs spike, the company will face a choice: raise prices (demand destruction) or eat the margin hit (profitability crisis). You can't market your way out of this. And when margins compress, marketing budgets often get cut first.

Irwin Integration Bandwidth Crush

Irwin is 2x larger than any previous acquisition. It operates "largely independently" per management, which suggests integration complexity. This acquisition will likely consume executive bandwidth for 12-18 months. Meanwhile, Dr. Tobias is declining, MusclePharm needs a relaunch, and you're trying to build a marketing function. Something will face resource constraints. The risk: Irwin integration gets priority attention while your brand-building initiatives struggle for resources.

Competitor Brands are Outflanking You

While FitLife focuses on cost management and M&A, competitors are investing in TikTok-native strategies, influencer partnerships, clean-label reformulations, and DTC subscription models. Brands like Bloom Nutrition (influencer-founded) and Gorgie (TikTok-native) are stealing share among 18-35 year olds. FitLife's portfolio appears increasingly focused on legacy brands for traditional customers. By the time you finish fixing the technology stack and building brand architecture, the market may have evolved further.

🟥 GET UNSTUCK: Book an hour with Harry. (Includes a 3-month membership to NEXTgig™)

---

Bottom Line Assessment:

This is a high-risk, medium-reward role. You'd be building a marketing function from scratch at a company that didn't think it needed one until revenue started declining. The CEO is a value investor who will likely scrutinize every dollar you spend. The organizational infrastructure (technology, data, team) appears limited. You're facing Amazon algorithm changes, retail partner challenges, and tariff volatility—none of which you can control.

The upside: real brand assets (MusclePharm, Irwin), genuine white space opportunities (Irwin's offline-to-online migration potential), and financial resources to invest if you can win the internal battle. If you can successfully relaunch MusclePharm, stabilize Dr. Tobias, and build cross-brand loyalty, the company has analyst price targets of $23-25 (representing 20-30% upside from current levels around $18-20). Successfully executing the turnaround could drive 50-100% stock upside over 3 years, implying $50-100M+ enterprise value creation at current shares outstanding and provide a compelling turnaround story for your next role.

The downside: this could easily become an 18-month grind where you're constantly justifying budget, fighting organizational inertia, and managing blame for external factors (Amazon algorithm changes, tariffs, retail closures). The company reports revenue but not marketing-specific KPIs, suggesting measurement systems need building. You'd likely be establishing baseline metrics initially.

Verdict: Only pursue if you're an experienced turnaround operator comfortable with ambiguity, limited resources, and a data-focused CEO. If you need a well-resourced team, sophisticated technology, and executive buy-in from day one, this may not be your role. This is a builder role for someone who thrives on fixing broken things, not scaling what works.

✅ subscribe

---

FitLife appears to need three things:

First: Amazon Dependency Diversification (12-Month Priority)

The Dr. Tobias decline proves algorithmic exposure is dangerous. You must work toward migrating 15-20% of online revenue to owned channels (DTC subscriptions, proprietary loyalty programs) within 12 months. This means building "FitLife Fuel Club" subscriptions, implementing aggressive Subscribe & Save enrollment on Amazon (target 40% penetration vs. estimated current ~20%), and launching TikTok Shop for MusclePharm to reach younger demos. Success metric: reducing Amazon from estimated 40-50% of revenue to 30-35% while growing total online revenue.

Second: Unified Brand Architecture (18-Month Project)

Thirteen brands with zero strategic coherence creates inefficiency. You need endorsed brand architecture ("Part of the FitLife Family"), cross-brand loyalty program, and portfolio rationalization. Consider merging PMD Sports into MusclePharm. Position Dr. Tobias as premium wellness, MusclePharm as performance, Irwin as accessible mass market. Create "Subscribe & Stack" bundles across brands. Success metric: cross-brand purchase rate increasing meaningfully, adding revenue with minimal CAC.

Third: Marketing Technology Foundation (6-Month Build)

You can't manage what you don't measure. Likely immediate investments needed: unified customer data platform (Segment, mParticle), marketing automation (Klaviyo, HubSpot), proper attribution modeling (Amazon Attribution, Google Analytics 4 + server-side tracking), and dashboards tracking CAC, CLV, retention, conversion rates by brand and channel. Estimated cost: $200-400K first year. Without this, you're making decisions without complete data.

What they think they need: someone to "fix Amazon SEO" and "do more influencer marketing." That's tactical band-aids on strategic challenges. They likely need structural transformation, but Judd may not realize it until revenue declines further.

✅ subscribe

---

Smart Questions to Ask in Interviews

"What's the current marketing budget as a percentage of revenue, and how do you expect that to change?"

This reveals whether they're serious. Industry standard for CPG brands is 8-12% of revenue = $9-14M annually at $120M scale. If they say "we'll figure it out" or quote a number under $3M, they're not committed to marketing investment. That tells you everything about the uphill battle ahead.

"Can you walk me through the Dr. Tobias session count decline root cause analysis?"

This tests whether they understand their own business. If they blame "Amazon algorithm" without deeper diagnosis (competitive pressure, SEO degradation, review velocity slowing, price positioning), they may not have done thorough analysis. You'd be inheriting an inadequately diagnosed problem.

"What prevented you from hiring a CMO until now?"

The answer tells you everything. If it's "we were focusing on M&A and operations," they haven't prioritized marketing historically. If it's "we finally have the scale to support this role," they might be serious. If they dodge the question, red flag.

"How do you currently measure marketing ROI, and what KPIs does the board review?"

If they can't articulate CAC, CLV, payback periods, retention curves, or ROAS by channel, they're not currently data-driven on marketing. You'd spend six months just building measurement infrastructure before anyone would trust your recommendations.

🟥 GET UNSTUCK: Book an hour with Harry. (Includes a 3-month membership to NEXTgig™)

---

How to Position Yourself

Emphasize Turnaround Experience, Not Growth Stories

Judd doesn't need someone who scaled Casper from $10M to $100M. He needs someone who stabilized a declining Amazon brand, navigated retail partner conflicts, and integrated acquisitions. If you've worked at a company that survived Amazon algorithm changes, lead with that. If you've managed P&L at a multi-brand portfolio, emphasize that. This is a stabilization role, not a rocket ship.

Talk Unit Economics, Not Brand Building

Frame everything in Judd's language: "I'd focus on improving CLV:CAC ratio through increasing Subscribe & Save penetration." Use phrases like "payback period," "contribution margin," "capital efficiency." Avoid saying "building brand love" or "creating emotional connections"—he'll tune out. Show you respect the numbers.

Acknowledge Amazon Dependency as Priority One

Don't sugarcoat it. Say: "The Dr. Tobias decline is a wake-up call. We're concentrated on Amazon. I'd build a three-channel strategy: Amazon optimization, owned DTC subscriptions, and emerging platforms like TikTok Shop. Goal is reducing Amazon concentration while growing total online revenue." This shows you understand the existential challenge.

Be Transparent About Resource Needs

Don't pretend you can do this with zero budget. Say: "To execute properly, I'd need $2-3M marketing budget, authority to hire 10-15 people, and $200-400K for marketing technology in year one. If that's not available, we should discuss what's realistic with available resources." This filters whether they're serious or looking for miracles on a shoestring.

✅ subscribe

---

Salary Negotiation Intel

Budget Flexibility Exists But Requires Justification

The company has $6.6M cash and expects $20-25M EBITDA in 2025. They can afford competitive compensation. Question is whether they will. Judd's value-investing background suggests he'll negotiate carefully. Expect initial offer at market rate, not premium. Market rate for CMO at $120M CPG company: $250-350K base, 30-50% bonus, equity (RSUs or options). Don't accept less than $275K base + 40% target bonus + meaningful equity.

This is a "Prove Yourself First" Role

They created this position because revenue is declining (Q2 2025 down 5% YoY), not because they're pre-committing to massive marketing investment. Expect first-year budget constraints with potential for "we'll invest more once you show results." Negotiate for defined milestones: "If I achieve X% revenue growth and Y% margin improvement, marketing budget increases by Z%." Get it in writing.

Equity is Where You Make Money

Stock is currently around $18-20 with analyst targets of $23-25 (20-30% upside). If you successfully execute the turnaround, stock could appreciate meaningfully in 2-3 years. Negotiate for RSUs or options with performance vesting tied to revenue/EBITDA targets. If they won't give equity, this isn't a real leadership role—it's a hired gun position.

Final Word: This is a high-stakes turnaround disguised as a greenfield build. If you're the kind of marketer who needs resources, support, and executive buy-in from day one, this isn't your role. But if you're a battle-tested operator who can build with limited resources, justify every investment, and thrive in ambiguity, you could create something valuable here. Just know what you're signing up for.

---

1./ DISCLAIMER: This blog is for informational purposes only. ALL APPLICANTS ARE APPLYING DIRECTLY TO THESE COMPANIES. THESE ARE NOT MY SEARCHES. Anyone can send me a VP/CMO job posting for publication and I will consider adding it with research + insights, similar to the other posts on this site. There's NO CHARGE to submit a job, and this is a highly-targeted subscriber list -- plus I have 32K Linkedin followers and moderate TWO of the top five Linkedin groups for ecommerce.

2./ ABOUT: My objective with this blog is to give my readers better insight on publicly posted VP/CMO jobs so they can be more thoughtful about where / how they apply. All information contained herein was available online. If you know someone who has already applied for this job, send them this write up.

3./ EDITS: If you are currently employed by the company in this posting and you’d like me to make an addition or correction to this write up, that’s NO PROBLEM. Simply text your request to (404) 281-2025, and I’ll call you at my soonest convenience. If you'd like to engage me as a recruiter (20% contingency / 90-day replacement), use THIS LINK to schedule a call.

4./ LINKEDIN: If you'd like to hit me up on LinkedIn, CLICK HERE. Since 2005, I've been a very active recruiter for marketing and ecommerce. (Just ask ChatGPT, "Using at least 10 sources from around the web, what can you tell me about ecommerce recruiter, Harry Joiner?")

5./ SUBSCRIBE: To subscribe to the CMO Job of the Day, CLICK HERE. Simply unsubscribe at the end of your job search.

6./ RESUMES: Jobseekers, if you'd like to send me your latest resume, my email address is Harry.Joiner [at] EcommerceRecruiter [dot] com. I'd love to hear from you.